Recently, Fool.com contributor Matt Frankel, CFP, decided to hit the “sell” button on Medicare Advantage company Clover Health (NASDAQ: CLOV). But unlike with most stocks, he didn’t sell this one because of the company’s long-term potential. In this Motley Fool Live video clip, recorded on July 2, Frankel discusses his reasons for selling Clover with The Motley Fool’s Chief Growth Officer Anand Chokkavelu.